Trial · NCT01710709
Adverse events35
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 35
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site pain | General disorders | Phase C: Open-Label IM Depot Maintenance Phase | 34 | 464 | 50 |
| other | Nasopharyngitis | Infections and infestations | Phase C: Open-Label IM Depot Maintenance Phase | 56 | 464 | 87 |
| other | Upper respiratory tract infection | Infections and infestations | Phase C: Open-Label IM Depot Maintenance Phase | 24 | 464 | 27 |
| other | Weight increased | Investigations | Phase C: Open-Label IM Depot Maintenance Phase | 62 | 464 | 66 |
| other | Akathisia | Nervous system disorders | Phase C: Open-Label IM Depot Maintenance Phase | 68 | 464 | 79 |
| other | Headache | Nervous system disorders | Phase C: Open-Label IM Depot Maintenance Phase | 29 | 464 | 37 |
| other | Tremor | Nervous system disorders | Phase C: Open-Label IM Depot Maintenance Phase | 28 | 464 | 38 |
| other | Anxiety | Psychiatric disorders | Phase C: Open-Label IM Depot Maintenance Phase | 46 | 464 | 60 |
| other | Depression | Psychiatric disorders | Phase C: Open-Label IM Depot Maintenance Phase | 26 | 464 | 35 |
| other | Insomnia | Psychiatric disorders | Phase C: Open-Label IM Depot Maintenance Phase | 51 | 464 | 54 |
| other | Restlessness | Psychiatric disorders | Phase C: Open-Label IM Depot Maintenance Phase | 23 | 464 | 27 |
| serious | Acute Myocardial Infarction | Cardiac disorders | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
| serious | Cardiac Arrest | Cardiac disorders | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
| serious | Myocardial Infarction | Cardiac disorders | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
| serious | Prinzmetal Angina | Cardiac disorders | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 3 |
| serious | Hyperprolactinaemia | Endocrine disorders | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
| serious | Chest Pain | General disorders | Phase C: Open-Label IM Depot Maintenance Phase | 2 | 464 | 2 |
| serious | Cholecystitis Acute | Hepatobiliary disorders | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
| serious | Kidney Infection | Infections and infestations | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
| serious | Arthropod Bite | Injury, poisoning and procedural complications | Phase C: Open-Label IM Depot Maintenance Phase | 1 | 464 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01710709/events